chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient woke up morning after injection with erythematous itchy rash all over body. His face, neck and chest appeared to be "sunburned." Treated by his private physician with Medrol dose pack. Improvement in rash within 2-3 days.
Information has been received from a consumer concerning her 14 year old female with penicillin allergy who on 27-MAR-2007 was vaccinated with 0.5 mL of Gardasil. On 27-MAR-2007 the patient experienced severe stomach pain. The patient's severe stomach pain persisted. Additional information has been requested.
Child presented with rash it does not seem to be associated with the fever or itching.  Has gotten progressively worse and began about 48 hours after being immunized with her one year shots.  She seems to be otherwise well. No new foods, detergents, exposures to others with illness.    No one else has a similar rash. No known allergies.  No new medications, including no fluoride.Child treated with benadryl.
Vaccine injection was given in the posterior left upper arm, started having discomfort within 3 hours gradually by 4-5 hours after unable to lift arm or reach without exteme soreness, lasting 3 days., followed by continued discomfort in middle of deltoid to under scapula and up into left neck. Pain has gradually worsened over last several months and know having numbness and tingling down left arm intermittently.
patients mom states that a few days later  there was a rash on his legs and arms  , flat macular rash , no fever , no pain , no trouble walking or sleeping , now resolved
Received expired covid vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired covid vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired covid vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired covid vaccine) had resolved.            Relevant concomitant medications were not reported.  The reporter stated that the vaccine the vaccine was out of refrigerator for days.  The treatment information was  not provided.
Enlarged and painful lymph nodes in left armpit , side of left breast ... right armpit and right side of breast  that has lasted almost a year. Exacerbation of fatigue, chronic cough and shortness of breath for almost a year now
extreme soreness in the R axillary region- Is this considered lymphadenopathy? I woke up noticing it and has been progressively gotten more sore- I'm a periodontist, R handed so it does affect my arm movement while I work.
Parent reports that a few hours after leaving clinic a small reddened ring with some swelling and warmth beginning forming near area of injection site.
Pt notified rite aid pharmacist 11/27/17 of continued pain/discomfort at injection site. Alleged  site in the crease of left elbow. Claims discomfort at site causes weakness in mobility and function of the arm. Concerns that after a month there is an issue with vaccine given or administration site causing prolonged pain and side effect.
Short term rapid racing of heart; This is a spontaneous report received from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 20Mar2021 at 14:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes and colitis. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN) for unknown indications from unknown dates. The patient previously received codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Mar2021 at 15:15, the patient experienced short term rapid racing of heart after the 15-minute wait time, around the 30-minute mark after the first dose, like being over caffeinated. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse event short term rapid racing of heart. The clinical outcome of the event short term rapid racing of heart was recovered on 20Mar2021.   Information about lot/batch number cannot be obtained. No further information is expected.
Within 24 hours of receiving the third dose of COVID vaccine, Moderna, I started to have patchy eczema on my elbows all the way up to my hands. This appeared on both arms. I went to see my dermatologist a few months later, when I had a scheduled appointment. My doctor looked at the patches and provided some topical cream. I was supposed to go back if the cream did not work, but I did not. I still have the eczema on my skin a year later.
First right sided parotitis - diag 12/26/ ER; next day right sided facial shingles;  - antibiotics and antiviral and a doctor's visit ; first day back to work was today  - SAW 5 DRS VISIT TOTAL - 1 er DR AND 4 OTHER DOCTORS
The pt experienced a 2-3 circular erythematous lesion with central clearing to the right triceps.
Information has been received from a physician referring to a patient of unknown age and gender. The patient's medical history, concomitant therapy and concurrent condition were not provided. On 25-JUL-2016, the patient was vaccinated with human papillomavirus HPV vaccine (manufacturer unknown) and RECOMBIVAX HB adult (dose, route, lot number and expiration date were unknown for both vaccines), both of which experienced temperature excursion. On an unknown date in 2016, the patient experienced soreness at the vaccine site, which lasted for 2 days. The patient wanted to check a titer for RECOMBIVAX HB, after a series of 3. The causal relationship between soreness for 2 days at the vaccine site and the both therapies was unknown. This is one of several reports from the same reporter. Additional information has been requested.
Severe shingles outbreak on lower abdomen/low back (one of the worst cases provider has ever seen) started with severe back pain resulting in ER visit, then progressed to shingles rash 3-4 days later.
PATIENT RETURNED TO THE PHARMACY 2 DAYS AFTER VACCINATION TO REPORT A RED SWOLLEN AREA ON HER INNER RIGHT ARM EXTENDING BELOW INJECTION SITE TO ELBOW.  INJECTION SITE APPEARED NORMAL NO REDNESS OR SORENESS. PATIENT STATES THE ARM AND SITE OF INJECTION WAS SORE BUT THEN THE REDNESS AND ITCHINESS STARTED TO APPEAR THE FOLLOWING DAY.
red vasculitis, serpintine pattern, no purpara @ the inject site; no systemic sx;
Day one: dizziness and nausea, soreness at injection site, headache Day two: Severe fatigue,  some nausea, severe headache, upper body aches, fever ranging 99.4 to 99.9, severe soreness/tenderness at injection site Day three: Fatigue, headache, upper body aches, mild fever ranging 98.9 to 99.5, soreness/tenderness at injection site Day four: Mild headache, mild soreness/tenderness at injection site
patient got her 1st dose and then ended up getting Covid with serious complications; patient got her 1st dose and then ended up getting Covid with serious complications; This is a spontaneous report from a contactable consumer (patient) via a Pfizer Sponsored Program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient got her 1st dose and then ended up getting Covid with serious complications on an unspecified date, and she now needs to get her 2nd dose and wanted to know if she should or not. The patient tested positive in COVID-19 on an unspecified date. The outcome of the events was unknown.  Batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
This is a spontaneous report from a contactable consumer. A 78-year-old female patient of unspecified ethnicity received PREVNAR 13 via an unspecified route of administration, on unknown date 6 weeks before this report, at a single dose for immunization. Relevant medical history and concomitant medications were not reported. The patient experienced trouble raising her arms, cough and fatigue on unknown date. The outcome of the events was unknown. Follow-up (08-MAY-2016): Follow-up attempts are completed. No further information is expected.
Pt recv vax on unknown day; post vax pt exp fever (104-105F), seizure & inconsolable crying; pt to E.R. & hosp; dx=allergic rx
Event of shot was fine. Felt fine in the evening. Woke up today with ache in muscles and feverish and it feels like a flu or cold.
Went to ER the morning of 11Jan91 /p spells of shaking & optisthotic posturing lasting 1-2 hrs.
allergic reaction; itchiness and redness around the neck and spreads down the whole body; itchiness and redness around the neck and spreads down the whole body; my face and one of my eyelids was swollen too; my face and one of my eyelids was swollen too; blotchy skin with raised blister like bumps, very itchy; blotchy skin with raised blister like bumps, very itchy; This is a spontaneous report from a contactable consumer. This 43-year-old non-pregnant female consumer (patient) reported that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EW0162 HNMC) via an unspecified route of administration on 15Apr2021 at 09:30 AM on left arm (at 43-year-old), as dose 2, single for COVID-19 immunization. The patient's medical history included skin allergy to certain non-precious metal, no food or medication allergies. The patient's concomitant medications were not reported. No other vaccine was received in four weeks and no other medications in two weeks. The patient did not have COVID prior vaccination and was not tested for COVID post vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN5318 HNMC) via an unspecified route of administration on 25Mar2021 at 09:30 PM on left arm as dose 1, single for COVID-19 immunization for itchy rash. On 08May2021 at 08: 30 PM, 3 weeks after the 2nd dose, patient started getting allergic reaction that starts around 8:30 pm with itchiness and redness around the neck and spreads down the whole body as the night progresses. It was event on her face and one of her eyelids was swollen too. It was happening every night for the last week - blotchy skin with raised blister like bumps, very itchy. It was mostly gone by the morning - sometimes still some bumps and itchiness on the lower legs, feet and hands, but it disappears entirely by mid-morning. No treatment was received for the events. The outcome of events was unknown.No follow-up attempts were possible. No further information was expected.
This spontaneous report as received from a registered nurse and refers to a patient of unknown age and gender. On 23-JUN-2014 the patient was intended to receive an unspecified meningococcal vaccine, was inadvertently administered LIQUID PEDVAXHIB 0.5 ml, intramuscular, lot # H010726, expiration date: 18-OCT-2014) due to nursing error. No adverse effects reported. Additional information is not expected because the reporter refused to contact the physician.
Headache, severe.  Possibly migraine, but not sure because I don't usually get severe headaches.  Headache lasted through 9/19/2010.  Tylenol, Ibuprofen did not affect the severity of headache.
On Saturday afternoon, I began to experience numbness and tingling in my right hand and arm.   Within a couple of days, the numbness and tingling was also experienced in my left hand and arm.   I then noticed I was beginning to have numbness and tingling in both of my legs.   On 10/28/2014, I saw my primary care doctor.    I experienced significant weakness in my legs, and I fell on 10/28/2014 while trying to stand and walk. The weakness in all four extremities continued to get worse, and on 10/30/2014, Dr. sent me to the ER.   I was seen there and eventually hospitalized.   I was released on 11/1/2014, with continued symptoms.
temp 102 to 103;soreness & swelling @ site & under arm;very lethargic;
FEVER; POUNDING HEADACHE (LIKE A MIGRAINE); TIREDNESS; NAUSEA; CHILLS; SEVERE BODY ACHES THROUGHOUT ARMS, LEGS, BACK, NECK AND MUSCLE WEAKNESS (ARMS AND LEGS).
erythema, tachycardia, tachypnea, headache, uncontrolled dystonic shaking
Initial health care professional report received on 01 Jun 2010: This patient received MENVEO (batch number 09100 for diluent and 029011 for lyophilized powder) unknown dose intramuscularly on an unknown date. On an unknown date, the patient was only administered the diluent of MENVEO. The outcome of the event was reported as unknown. The causality was not reported.
During 15 minute observation period after vaccination, patient left seating/observation area to purchase a soda and felt lightheaded and dizzy. Patient had sat down on carpet to avoid falling. After gaining composure, patient was helped up and escorted back to observation area and watched for another 15 minutes while consuming soda. Patient stated she had not eaten today and was probably hypoglycemic. Patient stated she was not diabetic when asked. After osbervation complete patient stated she was filling fine, however she was strongly encouraged to call for a ride, rather than driving herself home.
Bell's palsy; Foggy brain; Loss of feeling in lips and tongue; This is a spontaneous report from a contactable consumer (patient, self-reported). A 56-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, lot number and expiry dates were not provided) via an unspecified route of administration, in Arm Left, on 30Mar2021 at 17:30 (age at vaccination was 56 years), as a single dose for COVID-19 immunisation. Patient's medical history included diabetes and cancer survivor. The concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (lot number and expiry dates were not provided) via an unspecified route of administration, in Arm Left, on 09Mar2021 at 03:00 PM (age at vaccination was 56 years), as a single dose for Covid-19 immunisation. On 31Mar2021 at 09:00, the patient experienced bell's palsy, foggy brain and loss of feeling in lips and tongue. Patient did not receive other vaccines within 4 weeks or prior vaccination. Patient's treatment medications included unspecified steroid for the adverse events. The patient was hospitalized for the events on an unknown date in 2021 (for two and half days). Seriousness of the events was reported as hospitalization. Outcome of events was not recovered.  Information on the lot/batch number has been requested.
This case was reported by a other health professional via sales rep and described the occurrence of pertussis in a 3-month-old female patient who received PEDIARIX. On an unknown date, the patient received the 1st dose of PEDIARIX. In July 2017, less than a year after receiving PEDIARIX, the patient experienced pertussis (serious criteria GSK medically significant). On an unknown date, the outcome of the pertussis was unknown. It was unknown if the reporter considered the pertussis to be related to PEDIARIX. Additional details were reported as follows: The age at vaccination was not reported. The patient was diagnosed with pertussis, two and a half weeks ago after receiving her first dose of PEDIARIX.
1. Heart area felt tied up and as if it would explode 2. Fatigue, could barely move out of bed and felt hot 3. Pain at injection site after both doses 4. Symptoms resolved after one day, including sleep of 8+ hours
DEATHS; This spontaneous report received from a patient concerned 1,539 patients of unspecified age, sex, race and ethnicity. No past medical histories or concurrent conditions were reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: unknown expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination (Dose number in series 1). The batch numbers were not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified dates, 1,539 patients died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211233258- JANSSEN COVID-19 VACCINE Ad26.COV2.S. Deaths. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
she started coughing that occurred once in a while. It is a deep cough; sleeping a lot; Usual chills; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (she started coughing that occurred once in a while. It is a deep cough), SOMNOLENCE (sleeping a lot) and CHILLS (Usual chills) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939903) for COVID-19 vaccination.     The patient's past medical history included Smoker (Used to smoke 3 cigarettes a day. Quit smoking 17 months ago.), Walking difficulty (Before the vaccine, she went on vacation, came back and was not able to walk.), Muscle strain and Knee replacement. Concomitant products included CITALOPRAM for an unknown indication.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced COUGH (she started coughing that occurred once in a while. It is a deep cough), SOMNOLENCE (sleeping a lot) and CHILLS (Usual chills). At the time of the report, COUGH (she started coughing that occurred once in a while. It is a deep cough), SOMNOLENCE (sleeping a lot) and CHILLS (Usual chills) was resolving.            No treatment information was provided.  Earlier  patient used to smoke and never used to cough then. The coughing scared her.She was still not 100 percent.   Before the vaccination, patient went on vacation,came back and was not able to walk. patient  had a knee replacement, did blood work for it, took an X ray,  had pulled a muscle. She had to go to the hospital for this and did lung work there.This was not a reaction to the vaccine, patient mentioned as  this in passing from happening before.   Most recent FOLLOW-UP information incorporated above includes: On 01-Dec-2021: Follow-up information received contain Non significant information. On 02-Dec-2021: Non Significant Follow up
Vaccine clinic was using Johnson and Johnson earlier in the day and then changed over to Pfizer for first doses.  The vaccinator was used to drawing up 0.5 mL for J&J and drew up 0.5 mL of Pfizer and administered.  The mistake was caught right after the dose was administered, patient was notified and stayed an extra 15 minutes to observe for any adverse side effects. After half an hour, patient felt good and went home. Second dose appointment was scheduled as normal.
Oct 23, 3 days after the vaccines I had sharp pains in my left chest area during working out, after that through now (Nov 2), I started to have more chest pain, heart palpitations and fluttering.
My waist on the right side hurt a lot and my leg down to the bottom. I could not walk severe pain and I still have it and from that day I've had to spend money for the problem I now have.
Swelling of the arm where the vaccine was injected.  4/25/2021 - 4/28/2021; Area very hot to the touch. 4/25/2021 - 4/28/2021; Area very itchy. 4/25/2021 - 4/29/2021; Rash 4/26/2021 - 4/29/2021.
Approximately 20 minutes after dose I experienced numbing and swelling of lips.  Increased salivation and nausea and dizziness.   I took a Benadryl and went to bed.   When I woke the swelling had left.  I felt great, almost "high" for the next 24 hrs.  The following 24 hours  after that i experienced extreme fatigue.    My lips still feel a little odd.    I had no other side effects, not even a sore arm.
2 1/2-3 INCH RED SWOLLEN ARM - ROUNDED, HURTING AND ITCHING.
This spontaneous case was reported by a patient and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired doses) and NO ADVERSE EVENT (No adverse event) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025l21b, 03921a, 028l20a and 042l20a) for COVID-19 prophylaxis. No Medical History information was reported. On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired doses). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received expired doses) and NO ADVERSE EVENT (No adverse event) outcome was unknown. No concomitant information was provided. No treatment information was provided.
Swelling and redness.; Swelling and redness.; Pain and itching; Pain and itching; Large swollen area at injection site; Off-label use; This was a booster. Received the first 2 doses in March.; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3592) via an unspecified route of administration in the left arm on 29Sep2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date in Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date in Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 29Sep2021, the patient experienced swelling, redness, pain, itching and large swollen area at injection site. The patient reported pain and itching all were still occurring at the time of this report. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling, redness, pain, itching and large swollen area at injection site was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.